The Relationship of Age and Body Mass Index with Histopathological Features of Breast Carcinoma at RSUD Abdul Wahab Sjahranie Samarinda
Abstract
Background : Breast carcinoma is a disease characterized by the uncontrolled growth of breast epitel cells. Breast carcinoma is the most common cancer in the world and Indonesia. Breast cancer is caused by many factors, including age and obesity. Aim : This study aims to explain the relationship between age and body mass index with histopathological features of breast carcinoma at Abdul Wahab Sjahranie Hospital Samarinda. Methods : An analytical observational study with a cross-sectional approach was applied in this study. The research sample was taken from the anatomical pathology laboratory and medical record installation at Abdul Wahab Sjahranie Hospital Samarinda with a purposive sampling method. One hundred fifty-one samples were obtained from all breast cancer patients diagnosed histopathologically at RSUD Abdul Wahab Sjahranie Samarinda from the period 2020-2021 for this study. The data in this study were tested using the Chi-Square test. Result : The results showed that the analysis between age with histopathological type and grading of breast carcinoma, respectively, obtained p-value = 0.129 and p-value = 0.174, while BMI with histopathological type and grading of breast carcinoma obtained p-value = 0.467 and p-value = 0.199. Conclusion : There was no relationship between age and body mass index with histopathological features of breast carcinoma.
Full Text:
PDFReferences
American Cancer Society. What is Breast Cancer? [Internet]. American Cancer Society Website. 2019 [cited 2022 Jan 10]. Available from: https://www.cancer.org/cancer/breast-cancer/about/what-is-breast-cancer.html
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. 2021 May 1 [cited 2022 Mar 31];71(3):209–49. Available from: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21660
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2018 Nov 1 [cited 2022 Mar 31];68(6):394–424. Available from: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21492
World Health Organization. Breast cancer [Internet]. WHO. 2021 [cited 2022 Jan 10]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer
Global Cancer Observatory. Global Cancer Statistic in Indonesia [Internet]. 2020 [cited 2022 Jan 10]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
Prabandari F, Fajarsari D. Pengaruh Paritas dan Riwayat Penggunaan KB Hormonal terhadap Kejadian Kanker Payudara di RSU Dadi Keluarga Purwokerto. Pros Semin Nas dan Present Hasil-Hasil Penelit Pengabdi Masy. 2015;222–31.
Firasi AA, Yudhanto E. Hubungan Usia Terhadap Derajat Diferensiasi Kanker Payudara Pada Wanita. Diponegoro Med J (Jurnal Kedokt Diponegoro). 2016;5(4):327–36.
Rianti K, Hassan AH, Maulida M. Hubungan Usia dan Paritas dengan Gambaran Histopatologi Karsinoma pada Penderita Tumor Ganas Payudara. Pros Pendidik Dr. 2019;5(1):437–45.
Rahmadhani W, Bakhtiar R, Nugroho E, Irawiraman H, Duma K. Analisis Rentang Waktu Pemeriksaan Penderita Kanker Payudara di Pelayanan Kesehatan Samarinda. J Kesehat Andalas. 2020;8(4):215–22.
World Health Organization. Preventing Cancer [Internet]. 2019 [cited 2022 Jun 26]. Available from: https://www.who.int/activities/preventing-cancer
Centers fo Disease Control and Prevention. Obesity & Overweight [Internet]. 2022 [cited 2022 Jun 26]. Available from: https://www.cdc.gov/obesity/index.html
Neuhouser ML, Aragaki AK, Prentice RL, Manson JAE, Chlebowski R, Carty CL, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials. JAMA Oncol [Internet]. 2015 Aug 1 [cited 2022 Jun 27];1(5):611–21. Available from: https://pubmed.ncbi.nlm.nih.gov/26182172/
Leong ASY, Zhuang Z. The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology [Internet]. 2011 Jun [cited 2022 Jan 10];78(2):99–114. Available from: https://pubmed.ncbi.nlm.nih.gov/21677473/
Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology [Internet]. 2020 Aug 1 [cited 2022 Apr 23];77(2):181–5. Available from: https://pubmed.ncbi.nlm.nih.gov/32056259/
Agarwal I, Blanco L. Pathology Outlines - WHO classification [Internet]. Pathology Outlines. 2020 [cited 2022 Apr 23]. Available from: https://www.pathologyoutlines.com/topic/breastmalignantwhoclassification.html
Sulistiowati E, Haryono S, Onkologi B, Sakit R, Dharmais K, Sumeru J, et al. Kadar C-ERBB2 dalam Serum dan Saliva Pasien Kanker Payudara. Bul Penelit Kesehat. 2014;42(4):223–30.
Rahmatya A, Khambri D, Mulyani H. Hubungan Usia dengan Gambaran Klinikopatologi Kanker Payudara di Bagian Bedah RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2015;4(2):478–84.
Ellis IO, Collins L, Ichihara S, MacGrogan G. Invasive Carcinoma of No Special Type. World Heal Organ. 2012;2012(4):34–8.
Prawirohardjo AN, Soewoto W, Alfianto U. Hubungan Indeks Massa Tubuh dengan Grading Pada Kanker Payudara. Biomedika. 2018;10(1):41–5.
Ayoub NM, Yaghan RJ, Abdo NM, Matalka II, Akhu-Zaheya LM, Al-Mohtaseb AH. Impact of Obesity on Clinicopathologic Characteristics and Disease Prognosis in Pre- and Postmenopausal Breast Cancer Patients: A Retrospective Institutional Study. J Obes. 2019;
Mardiah H, Anggaeni RN, Rahmadhany H, Deswany ER. Correlation between Age and Body Mass Index ( BMI ) with Histopathological Features of Breast Cancer Patients in RSUP Haji Adam Malik Medan. Indones J Cancer. 2021;15(2):46–53.
Rukmi DK, Handayani D. Faktor Risiko Kanker Payudara Pada Wanita di RSUD Panembahan Senopati Bantul. Media Ilmu Kesehat. 2014;3(3):140–7.
Sidauruk JTS, Sitohang R, Pryta AS. Hubungan Usia Dengan Estrogen Receptor Pada Penderita Kanker Payudara di RSUD Dr. Pirngadi Medan Tahun 2018. Nommensen J Med. 2020;6(1):1–4.
Ataollahi MR, Sharifi J, Pakahad MR, Pakahad A. Breast cancer and associated factors: a review. J Med Life [Internet]. 2015 [cited 2022 Jul 30];8(4):6–11. Available from: https://pubmed.ncbi.nlm.nih.gov/28316699/
Hartaningsih NMD, Sudarsa IW. Kanker Payudara Pada Wanita Usia Muda Di Bagian Bedah Onkologi Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2002 – 2012. Med Udayana [Internet]. 2014;3(6). Available from: https://garuda.kemdikbud.go.id/documents/detail/1356988
Hsiao YH, Chou MC, Fowler C, Mason JT, Man YG. Breast cancer heterogeneity: mechanisms, proofs, and implications. J Cancer [Internet]. 2010 [cited 2022 Sep 8];1(1):6–13. Available from: https://pubmed.ncbi.nlm.nih.gov/20842218/
Chatamy FP. Hubungan Usia, Paritas, dan IMT dengan Ekspresi Protein Estrogen Reseptor (ER) dan Progesteron Reseptor (PR) pada Kanker Payudara Invasif No Special Type (NST) di RSUD Abdul Wahab Sjahranie Samarinda. Universitas Mulawarman; 2021.
Gershuni V, Li YR, Williams AD, So A, Steel L, Carrigan E, et al. Breast cancer subtype distribution is different in normal weight, overweight, and obese women. Breast Cancer Res Treat [Internet]. 2017 Jun 1 [cited 2022 Aug 4];163(2):375–81. Available from: https://pubmed.ncbi.nlm.nih.gov/28293912/
Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti Irani A. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One [Internet]. 2012 Dec 7 [cited 2022 Aug 22];7(12). Available from: https://pubmed.ncbi.nlm.nih.gov/23236502/
Maria IL, Sainal AA, Nyorong M. Risiko Gaya Hidup Terhadap Kejadian Kanker Payudara Pada Wanita. Media Kesehat Masy Indones. 2017;13(2):157.
Kementerian Kesehatan RI. Laporan Nasional Riskesdas 2018. Jakarta; 2018.
DOI: http://dx.doi.org/10.30872/j.kes.pasmi.kal.v7i2.8751
Refbacks
- There are currently no refbacks.
Indexing by :
